Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie : = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
- Alternative title
-
Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Deutsch
- Notes
-
Strahlentherapie und Onkologie. - 198, 10 (2022) , 966-969, ISSN: 1439-099X
- Keyword
-
Cisplatin
Postoperative Phase
Strahlentherapie
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2022
- Creator
- DOI
-
10.1007/s00066-022-01970-x
- URN
-
urn:nbn:de:bsz:25-freidok-2283841
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rühle, Alexander
- Nicolay, Nils
- Universität
Time of origin
- 2022
Other Objects (12)
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Health reports weekly & bi-weekly 1949
IGRT versus non-IGRT for postoperative head-and-neck IMRT patients: dosimetric consequences arising from a PTV margin reduction
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Health reports weekly & bi-weekly 1949
IGRT versus non-IGRT for postoperative head-and-neck IMRT patients: dosimetric consequences arising from a PTV margin reduction
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Chemoradiation for the management of locally advanced carcinoma uterine cervix: Comparative evaluation of concomitant weekly versus three weekly cisplatin
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer
Comparative evaluation of concomitant chemoradiation with weekly cisplatin and gemcitabine versus weekly cisplatin in the management of locally advanced carcinoma of uterine cervix
Weekly versus biweekly high-dose rate brachytherapy schedules in carcinoma cervix following concomitant chemoradiation with paclitaxel and carboplatin
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
A prospective randomized study comparing concurrent chemoradiation with weekly and 3 weekly cisplatin in locally advanced oropharyngeal carcinoma
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients
Health reports weekly & bi-weekly 1949
IGRT versus non-IGRT for postoperative head-and-neck IMRT patients: dosimetric consequences arising from a PTV margin reduction